Wenting Wu

Suzhou, 215000, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Targeting KIF11 degradation: Oxypeucedanin inhibits lung adenocarcinoma progression by disrupting the MCM2-CDK1 signaling pathway.

Targeting KIF11 degradation: Oxypeucedanin inhibits lung adenocarcinoma progression by disrupting the MCM2-CDK1 signaling pathway.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: February 10, 2026

Rosuvastatin Ameliorates the Initiation and Progression of Lung Adenocarcinoma via Facilitating PLK1 Inhibition.

Rosuvastatin Ameliorates the Initiation and Progression of Lung Adenocarcinoma via Facilitating PLK1 Inhibition.

Journal: Frontiers in bioscience (Landmark edition)

Published: December 16, 2025

A case of synchronous multiple primary lung cancer combining three different histological types.

A case of synchronous multiple primary lung cancer combining three different histological types.

Journal: SAGE open medical case reports

Published: August 12, 2025

Identification of Structurally Novel KRASG12C Inhibitors through Covalent DNA-Encoded Library Screening.

Identification of Structurally Novel KRASG12C Inhibitors through Covalent DNA-Encoded Library Screening.

Journal: Journal of medicinal chemistry

Published: February 11, 2025

Construction of Thiazole-Fused Dihydropyrans via Formal [4 + 2] Cycloaddition Reaction on DNA.

Construction of Thiazole-Fused Dihydropyrans via Formal [4 + 2] Cycloaddition Reaction on DNA.

Journal: Organic letters

Published: April 04, 2020

Inverse-Electron-Demand Diels-Alder Reactions for the Synthesis of Pyridazines on DNA.

Inverse-Electron-Demand Diels-Alder Reactions for the Synthesis of Pyridazines on DNA.

Journal: Organic letters

Published: October 27, 2018

Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.

Association of TERT Polymorphisms with Clinical Outcome of Non-Small Cell Lung Cancer Patients.

Journal: PloS one

Published: February 25, 2015

Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC.

Genetic Variants of the MDM2 Gene Are Predictive of Treatment-Related Toxicities and Overall Survival in Patients With Advanced NSCLC.

Journal: Clinical lung cancer

Published: December 15, 2014

Hsa-miR-196a2 functional SNP is associated with severe toxicity after platinum-based chemotherapy of advanced nonsmall cell lung cancer patients in a Chinese population.

Hsa-miR-196a2 functional SNP is associated with severe toxicity after platinum-based chemotherapy of advanced nonsmall cell lung cancer patients in a Chinese population.

Journal: Journal of clinical laboratory analysis

Published: November 13, 2012

Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.

Association between CASP8 and CASP10 polymorphisms and toxicity outcomes with platinum-based chemotherapy in Chinese patients with non-small cell lung cancer.

Journal: The oncologist

Published: July 31, 2012

Association of CASP7 polymorphisms and survival of patients with non-small cell lung cancer with platinum-based chemotherapy treatment.

Association of CASP7 polymorphisms and survival of patients with non-small cell lung cancer with platinum-based chemotherapy treatment.

Journal: Chest

Published: March 24, 2012

Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy.

Association of CASP3 polymorphism with hematologic toxicity in patients with advanced non-small-cell lung carcinoma treated with platinum-based chemotherapy.

Journal: Cancer science

Published: January 16, 2012

Showing 1-12 of 14

Last Updated: 09/26/2026